Pfizer Animal Health on Tuesday announced that it acquired fish vaccine manufacturer Microtek International.
Terms of the deal were not disclosed.
The New York-based biomedical and pharmaceutical giant said the move expands its commitment in food safety.
“The time is right for Pfizer Animal Health to enter the global market for aquaculture healthcare therapeutics,” said Juan Ramón Alaix, president of Pfizer Animal Health. “The integration of Microtek R&D into Pfizer Animal Health also will allow us to build a more diverse and innovative portfolio in biopharmaceuticals. The meat, dairy, egg and fish products that people enjoy for healthy living begin with a healthy food animal.”
William Kay, president and CEO Microtek, will take on a consulting role with Pfizer. British Columbia-based Microtek produces vaccines for a number of fish species farmed in Canada, the United States, Chile and parts of Europe.
All Aquaculture stories >